Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C13H16N4O6 |
| Molecular Weight | 324.2893 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[O-][N+](=O)C1=CC=C(O1)\C=N\N2CC(CN3CCOCC3)OC2=O
InChI
InChIKey=YVQVOQKFMFRVGR-VGOFMYFVSA-N
InChI=1S/C13H16N4O6/c18-13-16(14-7-10-1-2-12(22-10)17(19)20)9-11(23-13)8-15-3-5-21-6-4-15/h1-2,7,11H,3-6,8-9H2/b14-7+
| Molecular Formula | C13H16N4O6 |
| Molecular Weight | 324.2893 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 1 |
| Optical Activity | ( + / - ) |
Furaltadone is a veterinary product, which is marketed for the treatment and control of salmonella infection of poultry. In 1960th was investigated the antibacterial properties of this drug against human Rhodesian sleeping sickness. In three cases treated, two were apparently curated and the third relapsed. No toxic effects attributable to the product had been observed. However, the further investigation of the furaltadone in human was not provided.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Antiprotozoals effective in vitro against the scuticociliate fish pathogen Philasterides dicentrarchi. | 2002-06-03 |
|
| Bactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG. | 2000-12 |
|
| The therapeutic effect of 16 antimicrobial agents on Cryptosporidium infection in mice. | 1982-04 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13681531
oral: 250 mg every 6 hour
intravenous: 500 mg
Route of Administration:
Other
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:56:01 GMT 2025
by
admin
on
Mon Mar 31 17:56:01 GMT 2025
|
| Record UNII |
5X4V82ZN30
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C52588
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
||
|
WHO-VATC |
QJ01XX93
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
8059-21-0
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
SUPERSEDED | |||
|
59302-14-6
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
SUPERSEDED | |||
|
5X4V82ZN30
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
PRIMARY | |||
|
205-384-5
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
PRIMARY | |||
|
83454-29-9
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
SUPERSEDED | |||
|
74803
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
PRIMARY | |||
|
1256
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
PRIMARY | |||
|
C75249
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
PRIMARY | |||
|
CHEMBL1189513
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
PRIMARY | |||
|
811
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
PRIMARY | |||
|
9553856
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
PRIMARY | |||
|
m5593
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
PRIMARY | Merck Index | ||
|
94107-51-4
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
SUPERSEDED | |||
|
100000080675
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
PRIMARY | |||
|
42388
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
PRIMARY | |||
|
51728-00-8
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
SUPERSEDED | |||
|
139-91-3
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
PRIMARY | |||
|
8048-02-0
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
SUPERSEDED | |||
|
71-05-6
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
SUPERSEDED | |||
|
DTXSID4048016
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
PRIMARY | |||
|
SUB07831MIG
Created by
admin on Mon Mar 31 17:56:01 GMT 2025 , Edited by admin on Mon Mar 31 17:56:01 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
|
ENANTIOMER -> RACEMATE | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |